|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.70 SAR | -1.59% |
|
-2.17% | -7.62% |
| 07-17 | Derayah Financial Starts Avalon Pharma's Coverage at Buy | MT |
| 05-14 | Saudi Arabia's Edaa Executes Securities Quantity Increase for Avalon Pharma | MT |
Company Valuation: Middle East Pharmaceutical Industries Company
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 |
|---|---|---|
| Market Cap 1 | 2,436 | 2,224 |
| Change | - | -8.7% |
| Enterprise Value (EV) 1 | 2,479 | 2,253 |
| Change | - | -9.09% |
| P/E | 30.5x | 22.9x |
| PBR | 6.62x | 5.34x |
| PEG | 1.4x | 1.1x |
| Capitalization / Revenue | 6.18x | 4.83x |
| EV / Revenue | 6.29x | 4.89x |
| EV / EBITDA | 25x | 18.9x |
| EV / EBIT | 27.8x | 21.1x |
| EV / FCF | - | - |
| FCF Yield | - | - |
| Dividend per Share 2 | 1.143 | 1.383 |
| Rate of return | 1.64% | 2.18% |
| EPS 2 | 2.281 | 2.772 |
| Distribution rate | 50.1% | 49.9% |
| Net sales 1 | 394 | 460.5 |
| EBITDA 1 | 99.08 | 119.1 |
| EBIT 1 | 89.29 | 106.9 |
| Net income 1 | 79.85 | 97.01 |
| Net Debt 1 | 42.83 | 29.47 |
| Reference price 2 | 69.60 | 63.54 |
| Nbr of stocks (in thousands) | 35,000 | 35,000 |
| Announcement Date | 3/27/25 | 3/8/26 |
1SAR in Million2SAR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 556M | |
| 35.57x | 6.72x | 23.2x | 0.82% | 48.36B | |
| 18.36x | 2.08x | 9.81x | 1.3% | 35.8B | |
| 27.36x | 3.33x | 17.24x | 0.9% | 11.83B | |
| 26.28x | 3.88x | 15.8x | 0.6% | 11.48B | |
| 19.15x | 3.35x | 12.02x | 3.48% | 9.01B | |
| 16.13x | 2.08x | 6.99x | 3.22% | 6.99B | |
| 8.12x | 1.9x | 4.97x | 5.34% | 6.7B | |
| 33.27x | 3.78x | 16.1x | 0.24% | 6.42B | |
| Average | 23.03x | 3.39x | 13.27x | 1.99% | 15.24B | |
| Weighted average by Cap. | 26.04x | 4.14x | 15.76x | 1.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 4016 Stock
- Valuation Middle East Pharmaceutical Industries Company
Select your edition
All financial news and data tailored to specific country editions
